Poster Removal

Poster Removal

Fri. Oct 12, 2018 6:30 PM - 7:00 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Poster Removal

Poster Removal

Fri. Oct 12, 2018 6:30 PM - 7:00 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Industry Session

IS1-8

Targeting BCL2 to treat hematological cancers

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Harumi Mukai (Hepatology & Oncology, Medical Affairs, Medical, AbbVie GK)

Sponsor: AbbVie GK

Industry Session

IS1-9

Perspectives on Making Clinical Evidence Using Real World Data

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.9 (Osaka International Convention Center, 10F 1008)

Sponsor: Chugai Pharmaceutical Co., Ltd.

Industry Session

IS1-11

CLL treatment strategy and recent advances

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Hiroaki Fujimori (Oncology Department, Medical Affairs Division, Janssen Pharmaceutical K.K.)

Sponsor: Janssen Pharmaceutical K.K.

Luncheon Seminar

LS1-3

New therapeutic approaches in follicular lymphoma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Kensei Tobinai (National Cancer Center Hospital)

Sponsors: Chugai Pharmaceutical Co., Ltd./Nippon Shinyaku Co., Ltd.

Luncheon Seminar

LS1-4

New Treatment Strategy for Relapse and Refractory Multiple Myeloma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Takaaki Chou (Niigata Cancer Center Hospital Hematology/Oncology)

Sponsor: Takeda Pharmaceutical Company Limited

Luncheon Seminar

LS1-5

Management of Hepatitis B Virus Reactivation during and/or following Immunosuppressive Therapies and Chemotherapies

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Takahiro Fukuda (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)

Sponsor: Gilead Sciences K.K.

Luncheon Seminar

LS1-6

Myeloproliferative neoplasms diagnosis based on pathological and mutational criteria

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.6 (Osaka International Convention Center, 10F 1003)

Chair: Fumihiko Kimura (Division of Hematology, Department of Internal Medicine, National Defense Medical College)

Sponsors: Novartis Pharma K.K./SYSMEX CORPORATION

Luncheon Seminar

LS1-7

Recent Therapeutic Strategy in Peripheral T-cell Lymphoma

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Kazuhito Yamamoto (Department of Hematology and Cell Therapy, Aichi Cancer Center)

Sponsor: Meiji Seika Pharma Co., Ltd